PAR PHARMACEUTICAL COMPANIES, INC. - FORM 10-K - EX-23 - CONSENT OF DELOITTE & TOUCHE LLP - February 25, 2010

Attached files

file filename
10-K - FORM 10K - PAR PHARMACEUTICAL COMPANIES, INC.finaledgar200910k22510.htm
EX-32.2 - CERTIFICATION OF CFO - PAR PHARMACEUTICAL COMPANIES, INC.exhibit32cfo.htm
EX-32.1 - CERTIFICATION OF CEO - PAR PHARMACEUTICAL COMPANIES, INC.exhibit32ceo.htm
EX-10.6.9 - TERMS OF RESTRICTED SHARES AWARD - PAR PHARMACEUTICAL COMPANIES, INC.ex1069rsaterms.htm
EX-10.6.11 - TERMS OF RESTRICTED STOCK UNIT AWARD - PAR PHARMACEUTICAL COMPANIES, INC.ex10611rsuterms.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - PAR PHARMACEUTICAL COMPANIES, INC.exhibit31ceocert.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - PAR PHARMACEUTICAL COMPANIES, INC.exhibit31cfocert.htm
EX-14 - CODE OF ETHICS - PAR PHARMACEUTICAL COMPANIES, INC.exhibit14codeofethics.htm
EX-10.6.10 - TERMS OF STOCK OPTION - PAR PHARMACEUTICAL COMPANIES, INC.ex10610stockoptionterms.htm
EX-10.11.3 - AMENDMENT TO LEASE - PAR PHARMACEUTICAL COMPANIES, INC.exh101137thamdtoticelease.htm
EX-21 - LIST OF SUBSIDIARIES - PAR PHARMACEUTICAL COMPANIES, INC.exhibit21listofsubsidiariesa.htm

EXHIBIT 23


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement on Form S-3, (No. 333-160115) of our reports dated February 25, 2010 relating to the consolidated financial statements of Par Pharmaceutical Companies, Inc. and subsidiaries, and the effectiveness of Par Pharmaceutical Companies, Inc. and subsidiaries’ internal control over financial reporting appearing in the Annual Report on Form 10-K for the year ended December 31, 2009, and to the reference to us under the heading "Experts" in the Prospectus, which is part of the Registration Statement.


/s/ Deloitte & Touche LLP

Parsippany, NJ

February 25, 2010




Stock widget

Investing forum

PAR PHARMACEUTICAL COMPANIES, INC. Reports

Also read